Mirum Pharmaceuticals (MIRM) Other Non-Current Assets (2019 - 2026)

Mirum Pharmaceuticals' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $16.2 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 195.6% year-over-year to $16.2 million in Q1 2026; TTM through Mar 2026 was $16.2 million, a 195.6% increase from a year earlier, with the FY2025 full-year figure at $12.0 million, up 123.3% from the prior year.
• Other Non-Current Assets grew to $16.2 million in Q1 2026 per MIRM's latest filing, from $12.0 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $16.2 million in Q1 2026 and bottomed at $1.2 million in Q2 2023.
• The 5-year median for Other Non-Current Assets is $4.0 million (2024), against an average of $4.9 million.
• Across the five-year window, Other Non-Current Assets sank 34.24% in 2023 and surged 256.29% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $1.4 million in 2022, then surged by 201.37% to $4.2 million in 2023, then rose by 29.22% to $5.4 million in 2024, then soared by 123.3% to $12.0 million in 2025, then surged by 34.64% to $16.2 million in 2026.
• Per Business Quant, the three latest MIRM Other Non-Current Assets figures stand at $16.2 million (Q1 2026), $12.0 million (Q4 2025), and $9.9 million (Q3 2025).